Abstract:Importance: Accumulation of the protein tau is a defining characteristic of several neurodegenerative diseases. Thorough assessment of transgenic (Tg) mouse lines that replicate this process is critical for establishing the models used for testing anti-tau therapeutics in vivo.Objective: To define a consistent mouse model of disease for use in future compound efficacy studies.Design, Setting, and Participants: In this time course study, cohorts of Tg and control mice were euthanized at defined intervals. Collected brains were bisected down the midline. One half was frozen and used to measure the tau prion content, while the other half was fixed for immunostaining with anti-tau antibodies. All mice were maintained at the Hunters Point Animal Facility at the University of California, San Francisco, and all experiments were performed at the Mission Bay Campus of the University of California, San Francisco. Study animals were PS19, homozygous and hemizygous Tg(MAPT*P301S), and B6/J mice. The study dates were August 9, 2010, to October 3, 2016.Main Outcomes and Measures: Tau prions were measured using a cell-based assay. Neuropathology was measured by determining the percentage area positive for immunostaining in defined brain regions. A separate cohort of mice was aged until each mouse developed neurological signs as determined by trained animal technicians to assess mortality.Results: A total of 1035 mice were used in this time course study. These included PS19 mice (51.2% [126 of 246] male and 48.8% [120 of 246] female), Tg(MAPT*P301S+/+) mice (52.3% [216 of 413] male, 43.8% [181 of 413] female, and 3.9% [16 of 413] undetermined), Tg(MAPT*P301S+/-) mice (51.8% [101 of 195] male and 48.2% [94 of 195] female), and B6/J mice (49.7% [90 of 181] male and 50.3% [91 of 181] female). While considerable interanimal variability in neuropathology, disease onset, and tau prion formation in the PS19 mice was observed, all 3 measures of disease were more uniform in the Tg(MAPT*P301S+/+) mice. Comparing tau prion formation in Tg(MAPT*P301S+/+) mice with B6/J controls, the 95% CIs for the 2 mouse lines diverged before age 5 weeks, and significant (P < .05) neuropathology in the hindbrain of 24-week-old mice was quantifiable.Conclusions and Relevance: The assessment of disease progression using 3 criteria showed that disease onset in PS19 mice is too variable to obtain reliable measurements for drug discovery research. However, the reproducibility of tau prion formation in young Tg(MAPT*P301S+/+) mice establishes a rapid assay for compound efficacy in vivo.

Sustained high levels of neuroprotective, high molecular weight, phosphorylated tau in the longest-lived rodent

Amyloid beta and the longest-lived rodent: the naked mole-rat as a model for natural protection from Alzheimer's disease

Extended Postnatal Brain Development in the Longest-Lived Rodent: Prolonged Maintenance of Neotenous Traits in the Naked Mole-Rat Brain

Oxidative damage and amyloid‐β metabolism in brain regions of the longest‐lived rodents

Humanized APOE genotypes influence lifespan independently of tau aggregation in the P301S mouse model of tauopathy

O4‐08‐03: Loss of Tau Induces Age‐dependent Neurodegeneration

Unique neurophysiologic characteristics of the longest-living rodent: the naked mole rats

Behavioral and neuropathological characterization over the adult lifespan of the human tau knock-in mouse

Severe neurodegeneration in brains of transgenic rats producing human tau prions

Protein stability and resistance to oxidative stress are determinants of longevity in the longest-living rodent, the naked mole-rat

Endocrine function and neurobiology of the longest-living rodent, the naked mole-rat

Kinetics of Human Mutant Tau Prion Formation in the Brains of 2 Transgenic Mouse Lines

Loss of Tau Induces Age-Dependent Anaemia with Reduced Longevity in Mice

Humanized Tau Mice with Regionalized Amyloid Exhibit Behavioral Deficits but No Pathological Interaction

Vascular aging in the longest-living rodent, the naked mole rat

Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology

Differential compartmental processing and phosphorylation of pathogenic human tau and native mouse tau in the line 66 model of frontotemporal dementia

Negligible senescence in naked mole rats may be a consequence of well-maintained splicing regulation

CD44 correlates with longevity and enhances basal ATF6 activity and ER stress resistance

Identification and evaluation of midbrain specific longevity-related genes in exceptionally long-lived but healthy mice

Neuronal expression of human amyloid-β and Tau drives global phenotypic and multi-omic changes in